Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
11.86
+0.15 (1.28%)
Nov 5, 2024, 3:49 PM EST - Market open
Neumora Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$23.40
Upside
+97.30%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy → Hold Downgrades $18 → $15 | Buy → Hold | Downgrades | $18 → $15 | +26.48% | Nov 5, 2024 |
| Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +93.93% | Oct 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +152.95% | Oct 1, 2024 |
| Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +93.93% | Sep 12, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $29 | Buy | Reiterates | $29 | +144.52% | Sep 4, 2024 |
| Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +93.93% | Aug 7, 2024 |
| Needham | Needham | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +93.93% | Jul 22, 2024 |
| Mizuho | Mizuho | Buy Initiates $20 | Buy | Initiates | $20 | +68.63% | Jul 8, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $31 | Buy | Reiterates | $31 | +161.38% | Mar 28, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $20 → $22 | Buy | Maintains | $20 → $22 | +85.50% | Mar 18, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $24 → $31 | Buy | Maintains | $24 → $31 | +161.38% | Mar 8, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $21 → $20 | Buy | Maintains | $21 → $20 | +68.63% | Nov 8, 2023 |
| JP Morgan | JP Morgan | Buy Initiates $21 | Buy | Initiates | $21 | +77.07% | Oct 10, 2023 |
| B of A Securities | B of A Securities | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +51.77% | Oct 10, 2023 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Oct 10, 2023 |
| Guggenheim | Guggenheim | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +85.50% | Oct 10, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.